Ritz, Olga <br/><br/>
Targeting the intratumor heterogeneity in PMBL.  [electronic resource] 

 -  Cell cycle (Georgetown, Tex.)  2014 
 - 2317-8 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1551-4005 
<br/><br/><label>Standard No.: </label>10.4161/cc.29828  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Female<br/>Genetic Heterogeneity<br/>Humans<br/>Lymphoma, B-Cell--genetics<br/>Mediastinal Neoplasms--genetics<br/>Oncogenes<br/>Prednisone--therapeutic use<br/>Rituximab<br/>Secondary Prevention<br/>Vincristine--therapeutic use